The landscape for home medical equipment (HME) providers is shifting rapidly. With new legislation and regulatory proposals on the horizon, 2025 is proving to be a defining year for reimbursement, compliance and operational sustainability. 

The Prochant team was thrilled to attend the 2025 NICA Annual Conference, held June 20–21 in Miami, Florida. Represented by Lee Pratt, Gabby Whitmire and Jason Dillon, we spent two energizing days engaging with infusion pharmacy professionals from across the country and walked away with fresh insights and new connections. 

A large Arizona-based infusion provider with 19 outpatient centers and physician practice partnerships offers therapy for complex chronic conditions through both clinic-based and fully managed practice models.

The Department of Health and Human Services (HHS) has signaled the long-anticipated return of the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) in its FY 2026 budget request, and this time, the program is getting a major overhaul. 

This article outlines essential practices for billing miscellaneous codes correctly and leveraging tools like the PWK segment to support successful claim adjudication. 

Paula Roth, VP of Pharmacy Operations at Prochant, and Rachel Ewell, Director of Payer Contracts at Amerita, joined NHIA for a timely and tactical webinar focused on managing and preventing denials in the infusion space.

On May 22, the U.S. House of Representatives passed H.R. 1, informally known as the One Big, Beautiful Bill Act (OBBBA). This wide-ranging legislation includes several HHS-related provisions that could significantly impact providers of home medical equipment (HME) and infusion and pharmacy industries.

In the complex world of infusion reimbursement, experience matters. At Prochant, our infusion revenue cycle management (RCM) team brings together 158 years of combined expertise across every aspect of the revenue cycle. From intake to billing, collections to denial management, our experts have seen it all and solved it all. 

In this episode, the hosts explore a topic that’s becoming impossible to ignore across the infusion therapy landscape: the escalating talent crisis.

Denials are a revenue cycle problem that must be solved at both the front and back end. From intake to adjudication, home infusion providers need a comprehensive strategy that prioritizes prevention, streamlines resolution and strengthens payer collaboration.